Literature DB >> 9916307

Column switching in capillary liquid chromatography-tandem mass spectrometry for the quantitation of pg/ml concentrations of the free basic drug tolterodine and its active 5-hydroxymethyl metabolite in microliter volumes of plasma.

R Swart1, P Koivisto, K E Markides.   

Abstract

A capillary column switching system was developed for the determination of low, unbound concentrations of the basic drug tolterodine and its active 5-hydroxymethyl (5-HM) metabolite in human plasma. Free concentrations of tolterodine and 5-HM at pM and nM (pg/ml and ng/ml) levels were obtained by ultrafiltration of 40-400 microliters plasma at 37 degrees C. The free fraction (%) was independent of the plasma concentrations of the analytes. Detection of the analytes was performed by sheathless electrospray tandem mass spectrometry in the multiple-reaction monitoring mode. The selectivity of the mass spectrometric detection and the additional clean-up on the pre-column allowed direct injection of the ultrafiltrated plasma samples. Tolterodine and 5-HM were pre-concentrated on a reversed-phase capillary pre-column (1 cm x 200 microns) and subsequently backflushed onto the separation column (25 cm x 200 microns). The stability of the chromatographic system was good; a large number of ultrafiltrated plasma samples could be injected and the relative standard deviation of the retention times was typically < or = 1% (within-day). The accuracy was between 86 and 105% and the precision was between 1 and 7% without the use of an internal standard. Linear calibration curves were obtained between 100 pM and 100 nM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9916307     DOI: 10.1016/s0021-9673(98)00788-2

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  5 in total

1.  Identification of 2D-gel proteins: a comparison of MALDI/TOF peptide mass mapping to mu LC-ESI tandem mass spectrometry.

Authors:  Hanjo Lim; Jimmy Eng; John R Yates; Sandra L Tollaksen; Carol S Giometti; James F Holden; Michael W W Adams; Claudia I Reich; Gary J Olsen; Lara G Hays
Journal:  J Am Soc Mass Spectrom       Date:  2003-09       Impact factor: 3.109

Review 2.  Clinical pharmacokinetics of drugs used to treat urge incontinence.

Authors:  David R P Guay
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  A New Rapid and Sensitive Stability-Indicating UPLC Assay Method for Tolterodine Tartrate: Application in Pharmaceuticals, Human Plasma and Urine Samples.

Authors:  Ramesh Yanamandra; Chandra Sekhar Vadla; Umamaheshwar Puppala; Balaram Patro; Yellajyosula L N Murthy; Parimi Atchuta Ramaiah
Journal:  Sci Pharm       Date:  2011-12-05

4.  A validated LC-MS/MS method for the determination of tolterodine and its metabolite in rat plasma and application to pharmacokinetic study.

Authors:  Rihana Parveen Shaik; Srinivasa Babu Puttagunta; Chandrasekhar Bannoth Kothapalli; Bahlul Zayed Sh Awen; B R Challa
Journal:  J Pharm Anal       Date:  2013-05-24

5.  Isolation, Identification, and Characterisation of Degradation Products and the Development and Validation of a Stability-Indicating Method for the Estimation of Impurities in the Tolterodine Tartrate Formulation.

Authors:  Lakkireddy Prakash; Malipeddi Himaja; Rudraraju Vasudev
Journal:  Sci Pharm       Date:  2014-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.